Jeffrey Ubben Bausch Health Companies Inc. Transaction History

Value Act Holdings, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $632,830 - $2.12 Million	-89,636 Reduced 0.62%	14,341,265 $120 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $25.6 Million - $33 Million	-1,185,860 Reduced 7.59%	14,430,901 $330 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $53.5 Million - $67.4 Million	-2,324,842 Reduced 12.96%	15,616,761 $431 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $153,237 - $211,390	10,009 Added 0.06%	17,941,603 $373 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $2.08 Million - $2.69 Million	-101,555 Reduced 0.56%	17,931,594 $452 Million

Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $372 Million - $463 Million	18,033,149 New	18,033,149 $463 Million

262

207M

2.54M

6.46M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.27B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Value Act Holdings, L.P., based on Form 13F filings with the SEC.

Stay updated on Value Act Holdings, L.P. and Jeffrey Ubben with notifications on news.